Juvenile Idiopathic Arthritis: Features of DMARD and SAARD DrugsCurrent as of: January 24, 2018 |
|
Juvenile Idiopathic Arthritis: Features of DMARD and SAARD DrugsTopic OverviewMedicine will likely be an important part of your child's treatment. Treatment varies depending on the needs of each child, but certain medicines are often tried first. These are known interchangeably as disease-modifying antirheumatic drugs (DMARDs) and as slow-acting antirheumatic drugs (SAARDs). DMARDs/SAARDs include azathioprine, cyclosporine, etanercept, methotrexate, and sulfasalazine. DMARDs/SAARDs have a lot in common.
Although these medicines are often called "disease-modifying," it has been hard to prove that they truly prevent long-term joint damage. But they often relieve pain and swelling. Related InformationCredits
ByHealthwise Staff Current as ofJanuary 24, 2018
Current as of: January 24, 2018 |
Search the
Healthwise Knowledgebase Topic ContentsThis information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. To learn more about Healthwise, visit Healthwise.org. © 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. |